A Randomized Phase II Study of Chemoradiation and Pembrolizumab for Locally Advanced Cancer
The purpose of this study is to evaluate the safety and effectiveness of immunotherapy in combination with chemotherapy and radiation (chemoradiation) for the treatment of advanced cervical cancer. Pembrolizumab, a type of immunotherapy called a checkpoint inhibitor, will be administered after or during chemoradiation.
• Confirmed cervical cancer.
• Must have adequate organ function.